Main > ONCOLOGY (**) > Kidney Cancer>RCC>MET *** > Treatment > USA. E. Cabozantinib *** > (*) EU Approval Date: 2016. 09.09.>

---

previously received anti-angiogenic therapy


(*) EU Approval Date: 2016. 09.09.>'s products
This section has no products